| URN | urn:agi-cas:51-61-6 |
|---|---|
| Total Entities | 0 |
| Connectivity | 3850 |
| Name | dopamine |
| Pathway | Gap Junction Assembly |
|---|---|
| Young Onset SNCA Induced Parkinson's Disease | |
| Dopamine Metabolism in Parkinson's Disease | |
| Neurotoxin-Induced Parkinson's Disease | |
| Metals and Amyloid beta Toxicity | |
| Overt Hypothyroidism Influence on Thyroid-Stimulating Hormone Secretion | |
| Central Hypothyroidism Overview | |
| Tertiary Hypothyroidism Overview | |
| Induction of Apoptosis and Immediate Early Gene Activation in Hippocampal Neurons Following Seizures | |
| Phenylalanine and Tyrosine metabolism | |
| CNR1/2 -> membrane transport | |
| DRD2 -> TRPC1 transcription | |
| DRD1/3 -> potassium uptake | |
| DRD2/4 -> membrane transport | |
| DRD3 -> dopamine uptake | |
| Nociception-related DRD2 expression targets | |
| Nociception-related DRD1/5 expression targets | |
| CCKBR -> neurotransmitter uptake | |
| TAAR1 -> neurotransmitter uptake | |
| Epinephrine/Norepinephrine release cycle | |
| Dopamine release cycle | |
| Regulation of potassium flux | |
| Summarized nociception-related expression targets | |
| Regulation of calcium flux | |
| DopamineR2 -> AP-1/CREB/ELK-SRF signaling | |
| DopamineR2 -> NF-kB signaling | |
| DopamineR1 -> CREB/ELK-SRF signaling | |
| Dopamine/Gi Expression Targets | |
| Dopamine/Gs Expression Targets | |
| dopamine signaling pathway | |
| peripheral dopamine signaling pathway | |
| acetylcholine signaling pathway via nicotinic acetylcholine receptor | |
| epinephrine biosynthetic pathway | |
| norepinephrine biosynthetic pathway | |
| dopamine signaling pathway | |
| norepinephrine biosynthetic pathway | |
| epinephrine biosynthetic pathway | |
| norepinephrine biosynthetic pathway | |
| dopamine biosynthetic pathway | |
| epinephrine biosynthetic pathway |
| Group | Biofluids assayable substances |
|---|
| Source | ChemIDplus |
|---|
| Alias | 3-hydroxytyramine hydrobromide |
|---|---|
| 62-31-7 | |
| KW-3-060 | |
| dopamin guilini | |
| dopamin braun | |
| dopamin awd | |
| dopamex | |
| docard | |
| catabon | |
| cardiosteril | |
| cardiopal | |
| 3 hydroxy tyramine | |
| dopamin natterman | |
| Uramin | |
| dopamine hydrochloride and dextrose 5% | |
| 51-61-6 | |
| 50444-17-2 | |
| 1477-71-0 | |
| Revivan | |
| P498 cpd | |
| P-498 | |
| P 498 | |
| Oxytyramine | |
| NSC 173182 | |
| NSC 169105 | |
| m-Hydroxytyramine hydrochloride | |
| Intropin | |
| 3-Hydroxtyramine | |
| levodopamine | |
| levo dopamine | |
| l dopamine | |
| intropin iv | |
| inovan | |
| inotropin | |
| inopin | |
| inopan | |
| giludop | |
| dynos | |
| dopamin leopold | |
| dopmin e | |
| 4-(2-Aminoethyl)pyrocatechol HCl | |
| [(18)F]dopamine | |
| asl 279 | |
| [G-3H]Dopamine | |
| (G-3H)Dopamine | |
| tensamin | |
| beta-(3,4-Dihydroxyphenyl)ethylamine HCl | |
| 3,4-Dihydroxyphenethylamine HCl | |
| dopmin | |
| dopinga | |
| dopaminex | |
| dopamine hydrochloride in dextrose 5% | |
| drynalken | |
| 2-(3,4-Dihydroxyphenyl)ethylamine | |
| 4-(2-Aminoethyl)pyrocatechol | |
| 4-(2-Aminoethyl)catechol | |
| 4-(2-aminoethyl)benzene-1,2-diol | |
| 4-(2-Aminoethyl)-1,2-bezenediol | |
| [11C]dopamine | |
| [14C]dopamine | |
| [1S-3H]dopamine | |
| [2,2-2H2]dopamine | |
| [2S-3H]dopamine | |
| m-Hydroxytyramine HCl | |
| 4-(2-Aminoethyl)pyrocatechol hydrochloride | |
| [7-14C]dopamine | |
| [2H2]-dopamine | |
| 3,4 Dihydroxyphenethylamine | |
| 3,4-Dihydroxyphenethylamine hydrochloride | |
| 3,4-Dihydroxyphenylethylamine | |
| 4-(2-aminoethyl)-1,2-Benzenediol labeled with tritium | |
| 4-(2-Aminoethyl)-1,2-benzenediol | |
| 3-hydroxytyramine-HCl | |
| 3-Hydroxytyramine hydrochloride | |
| 3-Hydroxytyramine | |
| 3H-ADTN | |
| 3,4-dihydroxyphenyl-ethylamine | |
| Hydroxytyramine | |
| [3H]dopamine | |
| Dynatra | |
| Hydroxytyramin | |
| HSDB 3068 | |
| [3H]3,4-dihydroxyphenylethylamine | |
| EINECS 200-110-0 | |
| 4-(aminoethyl)catechol | |
| Dophamine | |
| Dopastat | |
| Dopaminum | |
| dopamines | |
| dopamine-3H | |
| dopamine-14C | |
| dopamine-1 | |
| Dopamine hydrochloride | |
| D2-dopamine | |
| EINECS 200-527-8 | |
| dopamine concentrate sterile | |
| a-(3,4-Dihydroxyphenyl)-b-aminoethane | |
| beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride | |
| dihydroxyphenylethylamine | |
| dipropyl DA | |
| Dopamin | |
| Dopamina | |
| 4-dihydroxyphenylethylamine | |
| dopamine | |
| Dopamine chloride | |
| alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane | |
| ASL-279 | |
| up 3,4-dihydroxyphenylethylamine |
| KEGG ID | C03758 |
|---|
| MedScan ID | 1003345 |
|---|
| HMDB ID | HMDB00073 |
|---|
| PharmaPendium Name | Dopamine Hydrochloride |
|---|
| CAS ID | 51-61-6 |
|---|---|
| 1477-71-0 | |
| 62-31-7 | |
| 50444-17-2 |
| PubChem SID | 134972588 |
|---|---|
| 135022549 | |
| 135124979 | |
| 148617 | |
| 207316 | |
| 748365 |
| PubChem CID | 681 |
|---|---|
| 65340 |
| IUPAC Name | 4-(2-aminoethyl)pyrocatechol |
|---|---|
| 4-(2-aminoethyl)pyrocatechol;hydrochloride | |
| 4-(2-aminoethyl)pyrocatechol hydrochloride |
| InChIKey | VYFYYTLLBUKUHU-UHFFFAOYSA-N |
|---|---|
| CTENFNNZBMHDDG-UHFFFAOYSA-N |
| Rotatable Bond Count | 2 |
|---|
| Molecular Weight | 153.178440 |
|---|---|
| 189.639380 | |
| 153.178440 | |
| 189.639380 | |
| 153.178440 | |
| 189.639380 | |
| 153.178440 | |
| 189.639380 |
| Molecular Formula | C8H11NO2 |
|---|---|
| C8H12ClNO2 |
| XLogP | -1.000000 |
|---|---|
| -1.000000 |
| ChEBI ID | 18243 |
|---|
| Reaxys ID | 1072822 |
|---|---|
| 4134622 | |
| 5529929 | |
| 8136385 |
| LinkUrl | http://rgd.mcw.edu/rgdweb/ontology/annot.html?acc_id=CHEBI:18243&species=All |
|---|